Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 66

Freebird lands at Capital One

American Express Ventures and Citi Ventures have exited flight insurance software developer Freebird in an acquisition by Capital One.

Aug 31, 2020

Fastly picks up Signal Sciences for $775m

O'Reilly's OATV vehicle will exit web cybersecurity software provider in a deal consisting of $200m in cash and $575m of Fastly stock.

Aug 28, 2020

JHTV tunes in 11 new spinouts

The TTO reported decreased spinout generation, licensing revenue and funding however marked a notable exit in the sale of Tissue Analytics.

Aug 28, 2020

Delivery Hero swoops for InstaShop in $360m deal

On-demand grocery delivery service InstaShop had reportedly raised just $7m prior to the acquisition, with Souq and Jabbar Internet exiting.

Aug 28, 2020

Afterpay arcs to Pagantis acquisition

Pagantis has agreed to be purchased by Afterpay in a deal sized at about $59m having raised more than $92m from backers including the Credit Suisse’s SPF Investment Management spinoff.

Aug 27, 2020

Cisco signs up for BabbleLabs acquisition

Dell Technologies Capital and Intel Capital are set to exit the audio enhancement technology provider, which has agreed to be bought by Cisco.

Aug 26, 2020

Govertis makes its way to ElevenPaths

The Telefónica subsidiary has bought cyber risk consultancy and software producer Govertis having previously invested through subsidiary ElevenPaths.

Aug 26, 2020

Bionano Genomics takes up Lineagen

University of Utah autism diagnosis service provider Lineagen has been snapped up in a transaction worth at least $9.6m in cash, stocks and liabilities.

Aug 26, 2020

Yumanity and Proteostasis pursue reverse merger

Yumanity Therapeutics will take over Nasdaq-listed Proteostasis in a reverse merger after raising more than $100m from investors including Biogen, Merck & Co, Pfizer and Sanofi.

Aug 26, 2020

Acadia absorbs Cersci for $52.5m

UT Dallas spinout Cersci Therapeutics has been acquired in a deal potentially worth nearly $940m, including a $52.5m upfront payment.

Aug 26, 2020
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here